iifl-logo

LIC MF Healthcare Fund Direct G

LIC MF Healthcare Fund Direct G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Direct G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Sudhanshu Asthana

Net Assets (Rs. cr)

103.11

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

LIC MF Healthcare Fund Direct G - Nav Details

Nav Date

:  23-Sep-2026

NAV [Rs.]

:  38.2525

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Direct G- NAV Chart

LIC MF Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
3.03
2.5
10.17
28.88
18.08
23.93
12.95
19.38
Category Avg
2.91
2
8.3
26.69
18.16
22
14.62
17.2
Category Best
3.78
4.76
11.72
34.99
30.1
25.39
18.62
32.09
Category Worst
2.12
-0.26
2.45
15.34
4.56
17.7
11.57
0.89

LIC MF Healthcare Fund Direct G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
Syngene Intl.25,000

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.095243610.40
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.29101189.57
EquityTorrent Pharma.Pharmaceuticals & Biotechnology6.45131306.65
EquityNeuland Labs.Pharmaceuticals & Biotechnology6.3828596.57
EquityApollo HospitalsHealthcare Services6.2372176.42
EquityNavin Fluo.Intl.Chemicals & Petrochemicals5.6567165.82
EquityAurobindo PharmaPharmaceuticals & Biotechnology5.17310505.33
EquityAster DM QualityHealthcare Services4.82657504.97
EquityZydus Lifesci.Pharmaceuticals & Biotechnology4.79425004.93
EquityGland PharmaPharmaceuticals & Biotechnology3.93140434.05
EquityFortis Health.Healthcare Services3.78430323.90
EquityGlobal HealthHealthcare Services3.19222523.29
EquityIpca Labs.Pharmaceuticals & Biotechnology3.18166043.27
EquityMetropolis HealtHealthcare Services3.17561293.26
EquityCohance LifePharmaceuticals & Biotechnology2.92659503.00
EquityMankind PharmaPharmaceuticals & Biotechnology2.89123272.98
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.88119942.97
EquityArtemis MedicareHealthcare Services2.88935292.96
EquityMax HealthcareHealthcare Services2.55252752.63
EquityDr Agarwal's HeaHealthcare Services2.54510012.61
EquityBioconPharmaceuticals & Biotechnology2.54635002.61
EquityOneSource Speci.Pharmaceuticals & Biotechnology2.21150092.28
EquitySyngene Intl.Healthcare Services0.97250001.00

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
50,329.19
Trustee/s:
LIC Mutual Fund Trustee P, Mr. Pradeep Jagannath Bhi
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Srividya Baliga
Fund Manager/s:
Sudhanshu Asthana
Auditors:
NA

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.